George M. Milne Jr. - 12 Jan 2026 Form 4 Insider Report for Amylyx Pharmaceuticals, Inc. (AMLX)

Role
Director
Signature
/s/ Joshua B. Cohen, as Attorney in Fact
Issuer symbol
AMLX
Transactions as of
12 Jan 2026
Net transactions value
$0
Form type
4
Filing time
14 Jan 2026, 16:08:37 UTC
Previous filing
09 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
MILNE GEORGE M JR Director C/O AMYLYX PHARMACEUTICALS, INC., 55 CAMBRIDGE PARKWAY, SUITE 6W, CAMBRIDGE /s/ Joshua B. Cohen, as Attorney in Fact 14 Jan 2026 0001179552

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMLX Common Stock Gift $0 -17,780 -2.1% $0.000000 812,881 12 Jan 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a bona fide gift for no consideration.